VBS — Vectus Biosystems Balance Sheet
0.000.00%
- AU$4.26m
- AU$3.45m
- AU$0.08m
Annual balance sheet for Vectus Biosystems, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | C2022 June 30th | C2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.72 | 5.78 | 1.28 | 2.95 | 0.809 |
Net Total Receivables | — | 0.977 | — | 1.43 | 0.976 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.92 | 6.91 | 3.73 | 4.46 | 1.84 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.079 | 0.073 | 0.208 | 0.173 | 0.182 |
Total Assets | 3 | 6.98 | 3.94 | 4.63 | 2.03 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.45 | 1.66 | 7.16 | 0.832 | 0.535 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.64 | 8.87 | 7.23 | 0.863 | 0.539 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -5.64 | -1.89 | -3.3 | 3.77 | 1.49 |
Total Liabilities & Shareholders' Equity | 3 | 6.98 | 3.94 | 4.63 | 2.03 |
Total Common Shares Outstanding |